# Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

> **NCT07485569** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Thyroid Cancer Stage IV
- Anaplastic Thyroid Cancer
- Differentiated Thyroid Cancer
- Poorly Differentiated Thyroid Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Personalised treatment

## Key facts

- **NCT ID:** NCT07485569
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07485569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07485569, "Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07485569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*